
Bellerophon Therapeutics (BLPH) Stock Forecast & Price Target
Bellerophon Therapeutics (BLPH) Analyst Ratings
Based on 7 analyst ratings
Strong Buy
Strong Buy 71%
Buy 29%
Hold 0%
Sell 0%
Strong Sell 0%
Bellerophon Therapeutics (BLPH) has been analyzed by 7 analysts, with a consensus rating of Strong Buy. 71% of analysts recommend a Strong Buy, 29% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.
This aggregate rating is based on analysts' research of Bellerophon Therapeutics and is not a guaranteed prediction by Public.com or investment advice.
This aggregate rating is based on analysts' research of Bellerophon Therapeutics and is not a guaranteed prediction by Public.com or investment advice.
Bellerophon Therapeutics (BLPH) Analyst Forecast & Price Prediction
Get the latest Bellerophon Therapeutics (BLPH) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Start investing in Bellerophon Therapeutics (BLPH)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Bellerophon Therapeutics (BLPH) Forecast
Analysts have given Bellerophon Therapeutics (BLPH) a Strong Buy based on their latest research and market trends.
According to 7 analysts, Bellerophon Therapeutics (BLPH) has a Strong Buy consensus rating as of Sep 23, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.
Wall Street analysts have set a price target of $17.71, reflecting a 0.00% increase from the current stock price.
Financial analysts have set a price target of $17.71, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.